Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gretchen Brewer

Optometrist Philadelphia, PA Doctor of Optometry

NPI 1235226671 CMS profile 56371

2329 Cottman Ave, Rossevelt Mall, Philadelphia, PA 19149

Open in the dashboard

General payments

$79,328

256 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Gretchen Brewer of Philadelphia, PA is reported in the CMS Open Payments database as having received $79,328 across 256 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,640 36
2024 General $7,654 31
2023 General $12,340 39
2022 General $30,427 45
2021 General $14,304 39
2020 General $1,125 23
2019 General $6,838 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gretchen Brewer
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Gretchen Brewer were reported at $6,640. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Gretchen Brewer Optometrist median Middle half National median
2019 $6,838 $159 $67–$371 $163
2020 $1,125 $72 $29–$165 $114
2021 $14,304 $125 $46–$292 $132
2022 $30,427 $162 $66–$374 $149
2023 $12,340 $177 $72–$406 $160
2024 $7,654 $188 $77–$427 $164
2025 $6,640 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CooperVision Inc. $53,675 128 payments
  2. Alcon Vision LLC $19,972 55 payments
  3. Bausch & Lomb, a division of Bausch Health US, LLC $1,388 22 payments
  4. Sight Sciences, Inc. $1,284 7 payments
  5. Johnson & Johnson Vision Care, Inc. $1,084 18 payments
  6. Bausch & Lomb Americas Inc. $1,018 14 payments
  7. AbbVie, Inc. $740 4 payments
  8. ABB Con-Cise Optical Group LLC $90 3 payments
  9. Allergan Inc. $23 1 payment
  10. Glaukos Corporation $20 1 payment
  11. Other $34 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $48,694 38 payments
  2. Food and Beverage $11,106 198 payments
  3. Travel and Lodging $9,915 13 payments
  4. Education $7,700 3 payments
  5. Consulting Fee $1,550 2 payments
  6. Grant $363 2 payments
Products named General payments · program years 2019–2025
  1. Clariti Contact Lens $20,874 42 payments
  2. Precision 1 $15,855 30 payments
  3. DAILIES TOTAL1 $14,582 25 payments
  4. Air Optix Color $10,500 16 payments
  5. Ray-Ban Contact Lens $10,000 4 payments
  6. Multiple Brands Contact Lens $5,515 21 payments
  7. Precision7 $5,158 11 payments
  8. CVI Contact Lens $4,674 21 payments
  9. MyDay Contact Lens $2,726 23 payments
  10. DAILIES TOTAL1 Multifocal $2,500 5 payments
  11. Other $12,896 114 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$16,659

Medicare's payments for the services billed

Medicare patients

178

Average age 74

Services billed

333

111 women, 67 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 36%
Diabetes 26%
Ischemic heart disease 20%
Chronic kidney disease 19%
Osteoporosis 17%
Depression 16%
Atrial fibrillation 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

256 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record